Hard-tissue substrates for evaluation of cariogenic and anti-cariogenic activity in situ.
Hard-tissue substrates include primarily human and bovine enamel and human dentin. They have been used for in situ studies in a natural or sound condition, as well as flattened or containing an in vitro-formed caries-like lesion. Human enamel and dentin are generally the substrates of choice for studies of coronal and root-surface caries, respectively, but bovine enamel appears to offer a suitable alternative for many studies of enamel caries. Substrates with caries-like lesions will respond more rapidly to changes in the intra-oral mineral equilibrium and will allow both demineralization and remineralization to be determined. Findings from some studies suggest that caries-like lesions may respond somewhat differently, depending upon the degree of mineralization of the surface layer. Because in vitro findings with dentin show it to be significantly more soluble in acid than enamel, results from a study that used dentin may not be directly applicable to enamel. Both enamel and dentin substrates can be used in thin-section models. Hard-tissue substrates can also differ, depending upon their intra-oral location. Locations that result in the accumulation of plaque will behave differently from those that are plaque-free. So that plaque would accumulate, substrates have been placed approximally, beneath a fabric or steel mesh, in a protected trough, beneath a metal band or within a depression on the buccal surface. For studies requiring a determination of both demineralization and remineralization, human enamel or dentin containing a surface-softened caries-like lesion and covered with a uniform natural plaque are the substrates of choice.
Mellberg
J R
JR
Colgate-Palmolive Company, Technology Center, Piscataway, New Jersey 08854.
D000818:Animals; D002326:Cariogenic Agents / Q000494:pharmacology*; D002327:Cariostatic Agents / Q000494:pharmacology*; D003731:Dental Caries / Q000473:pathology* / Q000503:physiopathology; D003743:Dental Enamel / Q000187:drug effects / Q000473:pathology*; D006801:Humans; D008954:Models, Biological
D002326:Cariogenic Agents; D002327:Cariostatic Agents